Every 10-Q that Petco Health and Wellness Company, Inc. (WOOF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow WOOF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WOOF filings page.
Petco Health & Wellness Company, Inc. (WOOF) reported essentially flat sales but stronger profitability for the quarter ended August 1, 2026. Net sales were $1.49 billion, up slightly year over year, with comparable sales increasing 0.6%. Services and other revenue grew, while supplies and companion animals declined, and consumables were stable.
Gross margin improved to 39.7% and operating income rose to $47.8 million, aided by a $6.8 million net tariff refund. Net income attributable to Class A and B‑1 stockholders increased to $38.7 million, and Adjusted EBITDA grew to $122.2 million, expanding margin to 8.2%. Free cash flow for the first half of fiscal 2026 was $60.8 million, supported by better working capital and tariff refunds. Petco refinanced its term loan, issued $600 million of senior secured notes maturing 2031, and ended the quarter with $293.5 million in cash and $487.6 million of ABL availability, while remaining in covenant compliance.
Petco Health and Wellness Company, Inc. reported net sales of $1.50 billion for the thirteen weeks ended May 2, 2026, up 0.2% from $1.49 billion, with comparable sales increasing 0.7%. Services and other revenue grew 6.8%, offsetting modest declines in consumables and supplies.
Gross margin improved slightly to 38.4%, and operating income rose to $24.6 million from $16.4 million. However, an $11.8 million loss on extinguishment and modification of debt following a major refinancing helped drive a net loss of $15.1 million, versus a $11.7 million loss a year earlier.
Adjusted EBITDA increased to $97.3 million from $89.4 million, while Free Cash Flow was negative $69.1 million. Petco refinanced its $1.5 billion term loan into a $900 million Amended First Lien Term Loan and $600 million of 8.25% Senior Secured Notes, ending the quarter with $166.8 million of cash and $487.6 million of ABL availability, or $654.4 million of total liquidity.
Petco Health and Wellness Company (WOOF) reported mixed quarterly results with revenue modestly down while profitability improved. Net sales decreased from $1.52 billion to $1.49 billion, a 2.3% decline, with comparable sales down 1.4%. Operating income rose to $43.0 million from $2.5 million a year earlier, and net income attributable to Class A and B-1 stockholders turned positive at $14.0 million versus a $24.8 million loss previously. Adjusted EBITDA increased from $83.5 million to $113.9 million. The company noted impairment charges on fixed and right-of-use assets totaling $3.4 million and $6.9 million for the thirteen and twenty-six week periods ended August 3, 2024. The ABL Revolving Credit Facility capacity is described at $581.0 million and borrowing costs reference base rate (1% floor) or Term SOFR (0% floor) plus margins of 25 bps or 125 bps. Cash equivalents included restricted money market balances of $1.0 million and $15.6 million at two reported dates.